发布时间:2020-12-23
近日,华银医药收到来自英国朗道实验诊断有限公司Randox的新型冠状病毒分子检测全球室间质评QCMD报告。报告显示,使用全组分冻干型新型冠状病毒核酸检测试剂(荧光PCR法)检测质评物,阴性符合率100%,阳性符合率100%——华银医药以"highly satisfactory"的评分圆满通过测评。
QCMD新冠病毒分子检测的全球室间质评计划主要用于评估实验室在临床水平及LOD值附近,以及其他非SARS冠状病毒存在时对新冠病毒的检测能力。
QCMD 2020 SARS-CoV-2 EQA Programme aims to assess laboratories in the molecular detection of SARS-CoV-2 at clinically appropriate levels, near the limit of detection of the assay as well as the specificity of molecular assay in the presence of other non-SARS coronaviruses.
* 0 (zero) is "highly satisfactory"
Tips 1
朗道国际质量评估计划(RIQAS)是全球最大的国际室间质评计划,有139个国家超过50000个实验室使用该计划。
RIQAS is the world's largest External Quality Assessment scheme with more then 50,000 laboratory participants spanning over 139 countries.
Tips 2
Detection kit for 2019-nCoV RNA (Multiple RT-PCR Fluorescence Probing) (Lyophilised) can be transported at room temperature and CE certified.
There are more options for testing respiratory pathogen infections now. Please contact Jolene Qiu (sales01@huayinbio.net) if you want to know more information.
Looking forward to the upcoming year with great optimism!